Nerve growth factor promotes reparative angiogenesis and inhibits endothelial apoptosis in cutaneous wounds of Type 1 diabetic mice

被引:134
|
作者
Graiani, G
Emanueli, C
Desortes, E
Van Linthout, S
Pinna, A
Figueroa, CD
Manni, L
Madeddu, P
机构
[1] Natl Inst Biostruct & Biosyst, Expt Med & Gene Thearpy Sect, I-07033 Sassari, Italy
[2] Univ Parma, Dept Pathol, I-43100 Parma, Italy
[3] Univ Austral Chile, Dept Pathol, Valdivia, Chile
[4] Sahlgrens Univ Hosp, Wallenberg Lab, Inst Cardiovasc Res, Gothenburg, Sweden
[5] Univ Sassari, I-07100 Sassari, Italy
关键词
angiogenesis; apoptosis; diabetes; vascular growth factor; wound healing;
D O I
10.1007/s00125-004-1414-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims/hypothesis. The neurotrophin nerve growth factor (NGF) is pro-angiogenic and facilitates wound repair. The present study was conducted to (i) assess the statement of NGF system components in diabetic wounds and (ii) evaluate whether NGF supplementation could prevent impairment of wound neoangiogenesis by diabetes. Methods. Skin wounds were produced in the interscapular region of streptozotocin-induced diabetic mice. NGF (1 mug per day in PBS) or vehicle was applied onto the ulcers for 3 days after punching. Non-diabetic mice were used as controls. Results. In wounds of untreated diabetic mice, endogenous levels of immunoreactive NGF were lower than those in wounds of non-diabetic mice (p<0.01). Immunohistochemical analysis showed down-regulation of tyrosine kinase receptor-A (TrkA) and up-regulation of p75 receptor in granulation tissue microvasculature. Local NFG administration prevented diabetes-induced expressional alterations, enhanced reparative capillarisation (p<0.01), and accelerated wound closure (p<0.01). This was associated with a three-fold increase in endothelial cell proliferation (p<0.01), while apoptosis was reduced by 50% (p<0.05). Quantitative RT-PCR documented a 5.5-fold increase in the expression of vascular endothelial growth factor-A (VEGF-A) by exogenous NGF in diabetic tissues (p<0.01). In in vitro preparations of human endothelial cells from derma, NGF increased the release of immunoreactive VEGF-A, and reduced high-glucose-induced apoptosis (p<0.05), the latter effect being inhibited by a VEGF-A receptor-2 antagonist. Conclusions/interpretation. Diabetic ulcers display distinct alterations in reparative angiogenesis and in the expression of NGF and its receptors. NGF supplementation corrects endogenous liabilities, facilitates vascular regeneration, and suppresses endothelial apoptosis seemingly via VEGF-A. Our findings unravel new mechanisms responsible for NGF reparative action.
引用
收藏
页码:1047 / 1054
页数:8
相关论文
共 50 条
  • [21] Active immunization against the vascular endothelial growth factor receptor flk1 inhibits tumor angiogenesis and metastasis
    Li, YW
    Wang, MN
    Li, HL
    King, KD
    Bassi, R
    Sun, HJ
    Santiago, A
    Hooper, AT
    Bohlen, P
    Hicklin, DJ
    JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (12) : 1575 - 1584
  • [22] Comparison of osteoprotegerin and vascular endothelial growth factor in normoalbuminuric Type 1 diabetic and control subjects
    Esteghamati, A.
    Arefzadeh, A.
    Zandieh, A.
    Sadaghiani, M. Salehi
    Noshad, S.
    Nakhjavani, M.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2013, 36 (07) : 474 - 477
  • [23] Nerve Growth Factor Gene Therapy Using Adeno-Associated Viral Vectors Prevents Cardiomyopathy in Type 1 Diabetic Mice
    Meloni, Marco
    Descamps, Betty
    Caporali, Andrea
    Zentilin, Lorena
    Floris, Ilaria
    Giacca, Mauro
    Emanueli, Costanza
    DIABETES, 2012, 61 (01) : 229 - 240
  • [24] Endothelial PAS domain protein 1 gene promotes angiogenesis through the transactivation of both vascular endothelial growth factor and its receptor, Flt-1
    Takeda, N
    Maemura, K
    Imai, Y
    Harada, T
    Kawanami, D
    Nojiri, T
    Manabe, I
    Nagai, R
    CIRCULATION RESEARCH, 2004, 95 (02) : 146 - 153
  • [25] Enzyme 15-lipoxygenase 1 promotes hypoxia-inducible factor 1α turnover and reduces vascular endothelial growth factor expression: implications for angiogenesis
    Zhong, Hua
    Wang, Ruoxiang
    Kelavkar, Uddhav
    Wang, Christopher Y.
    Simons, Jonathan
    CANCER MEDICINE, 2014, 3 (03): : 514 - 525
  • [26] Oroxylin A inhibits angiogenesis through blocking vascular endothelial growth factor-induced KDR/Flk-1 phosphorylation
    Ying Gao
    Na Lu
    Yun Ling
    Yan Chen
    Ling Wang
    Qing Zhao
    Qi Qi
    Wei Liu
    Haiwei Zhang
    Qidong You
    Qinglong Guo
    Journal of Cancer Research and Clinical Oncology, 2010, 136 : 667 - 675
  • [27] Nerve growth factor promotes formation of lumen-like structures in vitro through inducing apoptosis in human umbilical vein endothelial cells
    Han, Yaling
    Qi, Yanmei
    Kang, Jian
    Li, Na
    Tian, Xiaoxiang
    Yan, Chenghui
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2008, 366 (03) : 685 - 691
  • [28] Relationship between serum fibroblast growth factor 19 and vascular endothelial growth factor and soluble klotho protein in type 1 diabetic children
    Zhang, Yanjun
    Li, Guimei
    Xiao, Feifei
    Wang, Bang
    Li, Jianchang
    Jia, Xiuhong
    Sun, Yan
    Chen, Hongye
    BMC PEDIATRICS, 2023, 23 (01)
  • [29] Anticancer imidazoacridinone C-1311 inhibits hypoxia-inducible factor-1α (HIF-1α), vascular endothelial growth factor (VEGF) and angiogenesis
    Paradziej-Lukowicz, Jolanta
    Skwarska, Anna
    Peszynska-Sularz, Grazyna
    Brillowska-Dabrowska, Anna
    Konopa, Jerzy
    CANCER BIOLOGY & THERAPY, 2011, 12 (07) : 586 - 597
  • [30] Kringle 1 of human hepatocyte growth factor inhibits bovine aortic endothelial cell proliferation stimulated by basic fibroblast growth factor and causes cell apoptosis
    Xin, L
    Xu, R
    Zhang, Q
    Li, TP
    Gan, RB
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 277 (01) : 186 - 190